C12Y 304/2201
Streptopain
Official title: Streptopain (3.4.22.10)
C12Y304/2201 (Streptopain) appears on 6 US grants and 32 published applications in this corpus.
Search patents in C12Y- Granted patents
- 6
- Published applications
- 32
- Assignees
- 21
- Inventors
- 62
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 1 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 1 |
| 2019 | 0 | 2 |
| 2020 | 1 | 1 |
| 2021 | 0 | 4 |
| 2022 | 2 | 2 |
| 2023 | 0 | 6 |
| 2024 | 0 | 6 |
| 2025 | 1 | 5 |
| 2026 | 1 | 3 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Method of rapid extraction of DNA from saliva and qPCR amplification of group a Streptococcus DNA16 Jun 2026US 12,655,476 B2SalivIQ Diagnostics, Inc.
- Use of mutant of immunoglobulin degrading enzyme IdeE3 Jun 2025US 12,319,942 B2Shanghai Bao Pharmaceuticals Co., Ltd.
- Cysteine protease13 Dec 2022US 11,524,057 B2Hansa Biopharma AB
- Glucuronylation as a new acidic post-translational modification on therapeutic monoclonal antibodies21 Jun 2022US 11,366,123 B2Regeneron Pharmaceuticals, Inc.
- Cysteine proteases1 Sep 2020US 10,758,597 B2Hansa Biopharma AB
- Compositions and methods for targeted ides treatment of igg-related disorders3 Sep 2026US 2026/0258388 A1The Regents of the University of Michigan
- Regimen for enzymatic desensitisation16 Apr 2026US 2026/0102475 A1Hansa Biopharma AB
- Improved igg-degrading enzymes and methods of use thereof29 Jan 2026US 2026/0028610 A1AstraZeneca Ireland Limited
- Method of rapid extraction of dna from saliva and qpcr amplification of group a streptococcus dna11 Dec 2025US 2025/0376722 A1SalivIQ Diagnostics, Inc.
- Methods for enhancing adoptive cell transfer immunotherapies23 Oct 2025US 2025/0325640 A1Hansa Biopharma AB
Most cited
By later US patents